肺药

研究文章

儿科COVID-19:临床和影像学角度之间的相关性

表2

关系COVID-19临床分类、放射性的发现,和严重程度的分数。

变量 COVID-19的临床分类 价值
温和的 温和的 严重的 至关重要的

胸部x光发现异常 4 (33.3%) 9 (40.9%) 16 (57.1%) 16 (88.9%) 0.009
毛玻璃的透明和肺合并 1 (8.3%) 8 (36.3%) 11 (39.3%) 12 (66.7%) 0.024
支气管旁增厚和支气管旁的透明 3 (25%) 3 (22.7%) 5 (17.8%) 2 (11.1%) 0.961
胸膜腔积液 0 (0.0%) 2 (9.0%) 4 (14.3%) 1 (5.6%) 0.834
气胸 0 (0.0%) 1 (4.5%) 0 (0.0%) 2 (11.1%) 0.559
心脏肥大 0 (0.0%) 0 (0.0%) 2 (7.1%) 2 (11.1%) 0.361
COVID-19 RSNA胸部影像学发现暗示
10 (83.3%) 10 (40.9%) 12 (42.8%) 3 (16.7%)
Indeterminant 1 (16.7%) 11 (50.0%) 8 (28.6%) 7 (38.9%) 0.060
典型的 0 (0.0%) 0 (0.0%) 2 (7.2%) 4 (22.2%)
非典型的 1 (8.3%) 1 (4.5%) 6 (21.4%) 4 (22.2%)
COVID-19 RSNA CT胸部发现暗示
10 (83.3%) 10 (40.9%) 12 (42.9%) 3 (16.7%)
Indeterminant 1 (16.7%) 10 (45.5%) 7 (25%) 6 (33.3%) 0.043
典型的 0 (0.0%) 0 (0.0%) 2 (7.1%) 5 (27.8%)
非典型的 1 (8.3%) 2 (9%) 7 (25%) 4 (22.2%)
COVID-19严重性评估分数,中值(差) 0 (0 - 4) 4.5 (2 - 5) 3 (2 - 5) 3.5 (2 - 5) 0.017
RAPID-COVID得分,中值(差) 1 (1 - 4) 2 (1 - 6) 3 (1 - 6) 6 (1 - 8) 0.001
呼吸衰竭 0 (0.0%) 0 (0.0%) 6 (21.4%) 16 (88.9%) 0.001
胸部x光片得分,中值(差) 0 (-) 1 (6) 2 (1 - 6) 4 (1 - 6) < 0.001
胸部CT严重程度评分(CT-SS)、中值(差) 0 (0 - 4) 6(经历) 6 (0 - 14) 24(银幕上) < 0.001

RSNA:北美放射学会专家共识声明;RAPID-COVID得分:快速评估既往症,警察乙,成像疾病,dyspnea-COVID得分。 是至关重要的; 是非常重要的。